WallStSmart

Amrize Ltd (AMRZ)vsKnife River Corporation (KNF)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 272% more annual revenue ($11.91B vs $3.20B). AMRZ leads profitability with a 9.7% profit margin vs 4.6%. AMRZ appears more attractively valued with a PEG of 1.37. KNF earns a higher WallStSmart Score of 57/100 (C).

AMRZ

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

KNF

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 4.5Value: 3.3Quality: 6.0
Piotroski: 1/9Altman Z: 2.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

KNFSignificantly Overvalued (-88.4%)

Margin of Safety

-88.4%

Fair Value

$42.78

Current Price

$73.05

$30.27 premium

UndervaluedFair: $42.78Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ1 strengths · Avg: 8.0/10
Price/BookValuation
2.1x8/10

Reasonable price relative to book value

KNF3 strengths · Avg: 8.0/10
Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
16.0%8/10

16.0% revenue growth

EPS GrowthGrowth
36.1%8/10

Earnings expanding 36.1% YoY

Areas to Watch

AMRZ4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

KNF4 concerns · Avg: 3.5/10
PEG RatioValuation
1.624/10

Expensive relative to growth rate

P/E RatioValuation
31.8x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
4.6%3/10

4.6% margin — thin

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book. PEG of 1.37 suggests the stock is reasonably priced for its growth.

Bull Case : KNF

The strongest argument for KNF centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 16.0% demonstrates continued momentum.

Bear Case : AMRZ

The primary concerns for AMRZ are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : KNF

The primary concerns for KNF are PEG Ratio, P/E Ratio, Profit Margin. Thin 4.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

AMRZ profiles as a value stock while KNF is a growth play — different risk/reward profiles.

KNF is growing revenue faster at 16.0% — sustainability is the question.

KNF generates stronger free cash flow (-136M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KNF scores higher overall (57/100 vs 49/100) and 16.0% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.

Visit Website →

Knife River Corporation

BASIC MATERIALS · BUILDING MATERIALS · USA

Knife River Corporation provides aggregates-based construction materials and contracting services in the United States. The company is headquartered in Bismarck, North Dakota.

Want to dig deeper into these stocks?